GD Lifescience
Board
2 directors, since incorporationDirector (not named in the articles)
since 07-06-2019
term without a fixed end
listed in the 2025 annual accounts, filed on 24-06-2026
Director (not named in the articles)
since 07-06-2019
term without a fixed end
listed in the 2025 annual accounts, filed on 24-06-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 17-06-2019
Mandates through the years
2 names, the dashed line is todayDirector (not named in the articles)
Director (not named in the articles)
Board
Mandates as a list
-
- Director (not named in the articles), from 07-06-2019 to date
-
- Director (not named in the articles), from 07-06-2019 to date
Control
Founders
,
This company
GD Lifescience
Equity €524,259
Profit €504,187 in 2025
Capital
- Contribution
- €20,000
- Shares
- 200
- Contribution per share
- €100
- Equity per share
- €2,621 in 2025
- Source
- deed of 17-06-2019
Articles of association
deed of 17-06-2019 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Procedure- en expertisekosten voor helft ten laste overdrager en helft ten laste koper(s) naar evenredigheid bij meerdere kopers, overdracht…”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- “TITEL V. ALGEMENE VERGADERING Artikel 15. Organisatie en bijeenroeping Ieder jaar wordt een gewone algemene vergadering van aandeelhouders…”
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
- No statutory auditor
Shareholders
At incorporation
deed of 17-06-2019 ↗
- 100 shares (50%) · €10,000
- 100 shares (50%) · €10,000